These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 37399709)

  • 1. In vitro bioevaluation and docking study of dihydrosphingosine and ethambutol analogues against sensitive and multi-drug resistant Mycobacterium tuberculosis.
    Linhares LA; Dos Santos Peixoto A; Correia de Sousa LA; Lucena Laet JP; da Silva Santos AC; Alves Pereira VR; Carneiro Neves MM; Ferreira LFGR; Hernandes MZ; de la Vega J; Pereira-Neves A; San Feliciano A; Olmo ED; Schindler HC; Montenegro LML
    Eur J Med Chem; 2023 Oct; 258():115579. PubMed ID: 37399709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacious In Vitro and In Vivo Effects of Dihydrosphingosine-Ethambutol Analogues Against Susceptible and Multi-drug-resistant Mycobacterium tuberculosis.
    Olmo ED; Molina-Salinas GM; Bini EI; González-Hernández S; Bustos LA; Escarcena R; Marquina-Castillo B; Mata-Espinosa D; Barrios-Payán J; González-Ramírez D; Fernández SS; San Feliciano A; Hernández-Pando R
    Arch Med Res; 2016 May; 47(4):262-70. PubMed ID: 27664485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis and antimycobacterial evaluation of novel adamantane and adamantanol analogues effective against drug-resistant tuberculosis.
    Alsayed SSR; Lun S; Payne A; Bishai WR; Gunosewoyo H
    Bioorg Chem; 2021 Jan; 106():104486. PubMed ID: 33276981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High fluoroquinolone resistance proportions among multidrug-resistant tuberculosis driven by dominant L2 Mycobacterium tuberculosis clones in the Mumbai Metropolitan Region.
    Dreyer V; Mandal A; Dev P; Merker M; Barilar I; Utpatel C; Nilgiriwala K; Rodrigues C; Crook DW; ; Rasigade JP; Wirth T; Mistry N; Niemann S
    Genome Med; 2022 Aug; 14(1):95. PubMed ID: 35989319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection by GenoType MTBDRsl test of complex mechanisms of resistance to second-line drugs and ethambutol in multidrug-resistant Mycobacterium tuberculosis complex isolates.
    Brossier F; Veziris N; Aubry A; Jarlier V; Sougakoff W
    J Clin Microbiol; 2010 May; 48(5):1683-9. PubMed ID: 20335420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Determination of in vitro synergy by a checkerboard method when 3 core antimicrobial agents of the retreatment new scheme combined against MDR-MTB and XDR-MTB].
    Zhang LL; Yang H; Xiao HP; Lu JM; Sha W; Zhang Q
    Zhonghua Jie He He Hu Xi Za Zhi; 2016 Jun; 39(6):464-8. PubMed ID: 27289577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meropenem-clavulanate has high in vitro activity against multidrug-resistant Mycobacterium tuberculosis.
    Davies Forsman L; Giske CG; Bruchfeld J; Schön T; Juréen P; Ängeby K
    Int J Mycobacteriol; 2015 Mar; 4 Suppl 1():80-1. PubMed ID: 27128620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of tetracycline analogs against multidrug-resistant and extensive drug resistance clinical isolates of Mycobacterium tuberculosis.
    Zhang C; Ouyang Q; Zhou X; Huang Y; Zeng Y; Deng L; Lin D; Zheng W
    Tuberculosis (Edinb); 2023 May; 140():102336. PubMed ID: 36963294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of collinin isolated from the leaves of Zanthoxylum schinifolium against multidrug- and extensively drug-resistant Mycobacterium tuberculosis.
    Kim S; Seo H; Mahmud HA; Islam MI; Lee BE; Cho ML; Song HY
    Phytomedicine; 2018 Jul; 46():104-110. PubMed ID: 30097109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the Potential Inhibition of Candidate Drug Molecules for Clinical Investigation Based on their Docking or Crystallographic Analyses against
    Dey R; Nandi S; Samadder A; Saxena A; Saxena AK
    Curr Top Med Chem; 2020; 20(29):2662-2680. PubMed ID: 32885754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimycobacterial compound of chitosan and ethambutol: ultrastructural biological evaluation in vitro against Mycobacterium tuberculosis.
    Oliveira MEFAG; Silva YJA; Azevedo LA; Linhares LA; Montenegro LML; Alves S; Amorim RVS
    Appl Microbiol Biotechnol; 2021 Dec; 105(24):9167-9179. PubMed ID: 34841463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolomic analysis of Mycobacterium tuberculosis reveals metabolic profiles for identification of drug-resistant tuberculosis.
    Chaiyachat P; Kaewseekhao B; Chaiprasert A; Kamolwat P; Nonghanphithak D; Phetcharaburanin J; Sirichoat A; Ong RT; Faksri K
    Sci Rep; 2023 May; 13(1):8655. PubMed ID: 37244948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of ubiA mutations and high-level of ethambutol resistance among Mycobacterium tuberculosis Thai clinical isolates.
    Tulyaprawat O; Chaiprasert A; Chongtrakool P; Suwannakarn K; Ngamskulrungroj P
    Tuberculosis (Edinb); 2019 Jan; 114():42-46. PubMed ID: 30711156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of (-)-deoxypergularinine, on its own and in combination with anti-tubercular drugs, against resistant strains of Mycobacterium tuberculosis.
    Nam KW; Jang WS; Jyoti MA; Kim S; Lee BE; Song HY
    Phytomedicine; 2016 May; 23(5):578-82. PubMed ID: 27064017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benzothiazole analogs as potential anti-TB agents: computational input and molecular dynamics.
    Venugopala KN; Khedr MA; Pillay M; Nayak SK; Chandrashekharappa S; Aldhubiab BE; Harsha S; Attimard M; Odhav B
    J Biomol Struct Dyn; 2019 Apr; 37(7):1830-1842. PubMed ID: 29697293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole-Genome Sequencing for Resistance Prediction and Transmission Analysis of Mycobacterium tuberculosis Complex Strains from Namibia.
    Claassens M; Dreyer V; Nepolo E; Mokomele Q; van Rooyen G; Ruswa N; Günther G; Niemann S
    Microbiol Spectr; 2022 Oct; 10(5):e0158622. PubMed ID: 36165641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel indolinone-tethered benzothiophenes as anti-tubercular agents against MDR/XDR M. tuberculosis: Design, synthesis, biological evaluation and in vivo pharmacokinetic study.
    Eldehna WM; Mahmoud ST; Elshnawey ER; Elsayed ZM; Majrashi TA; El-Ashrey MK; Rashed M; Hemeda LR; Shoun AA; Elkaeed EB; El Hassab MA; Abdel-Aziz MM; Shahin MI
    Bioorg Chem; 2024 Feb; 143():107009. PubMed ID: 38070474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of Semi-Synthetic Mulinanes against MDR, Pre-XDR, and XDR Strains of
    Martínez-González MA; Peña-Rodríguez LM; Uc-Cachón AH; Bórquez J; Simirgiotis MJ; Barrios-García HB; Hernández-Pando R; Loyola LA; Areche C; Dzul-Beh AJ; Barrios-Payán JA; Mata-Espinosa D; Escalante-Erosa F; García-Sosa K; Molina-Salinas GM
    Metabolites; 2021 Dec; 11(12):. PubMed ID: 34940634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First insights into circulating XDR and pre-XDR Mycobacterium tuberculosis in Southern Brazil.
    Salvato RS; Costa ERD; Reis AJ; Schiefelbein SH; Halon ML; Barcellos RB; Unis G; Dias CF; Viveiros M; Portugal I; da Silva PEA; Kritski AL; Perdigão J; Rossetti MLR
    Infect Genet Evol; 2020 Mar; 78():104127. PubMed ID: 31783187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Tuberculosis caused by XDR resistant Mycobacterium tuberculosis in Poland. Microbiological and molecular analysis].
    Augustynowicz-Kopeć E; Zwolska Z
    Pneumonol Alergol Pol; 2007; 75(1):32-9. PubMed ID: 17541910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.